Macular Degeneration Trial, Recruiting NCT06955611 Sponsor: Hywel Dda Health Board Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT06955611
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have diabetes and have been referred to the hospital eye service to check for possible diabetic eye disease affecting the central part of your vision (maculopathy) or early changes to the blood vessels at the back of your eye (pre-proliferative retinopathy) at Hywel Dda University Health Board

Who may not be able to join:

  • You are under 18 years old
  • You have already been diagnosed with swelling at the back of your eye caused by diabetes (diabetic macular oedema)
  • You have an advanced form of diabetic eye disease where new abnormal blood vessels have started growing at the back of your eye (proliferative diabetic retinopathy)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eirini Skiadaresi, MD, Hywel Dda University Health Board

Phone: 01437773823

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hywel Dda Health Board
Registry
ClinicalTrials.gov
Start date
20 November 2024
Est. completion
1 August 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Time from referral to treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov